Lead Product(s) : MIV-711
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study demonstrated significant effect on changes in bone and cartilage degradation after six months of treatment with MIV-711.
Product Name : MIV-711
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 20, 2020
Lead Product(s) : MIV-711
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable